Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
20 hedge funds and large institutions have $1.1M invested in Celgene Corporation Contingent Value Rights in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
164% more capital invested
Capital invested by funds: $415K → $1.1M (+$682K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 19 → 20 (+1)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
+$25.7K |
| 2 |
Koshinski Asset Management
Decatur,
Illinois
|
+$23.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.64K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.33K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
-$152K |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
-$98K |
| 3 |
DAM
Deltec Asset Management
New York
|
-$57.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.97K |
CELGZ Hedge Fund Activity: Q3 2018 in Review
20 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q3 2018, worth a combined $1.1M — up 164% from $415K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CELGZ positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Dynamic Advisor Solutions, opening a new position worth an estimated $25.7K. The largest seller was Cannell & Co, cutting an estimated $152K.
- 20 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q3 2018, up from 19 in Q2 2018.
- Funds reported $1.1M of Celgene Corporation Contingent Value Rights stock for Q3 2018, up 164% quarter-over-quarter.
- 3 funds opened new Celgene Corporation Contingent Value Rights positions in Q3 2018 and 2 closed out, a net change of +1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q3 2018 was Dynamic Advisor Solutions, an estimated $25.7K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q3 2018 was Cannell & Co, an estimated $152K sold.
Based on aggregated 13F filings for Q3 2018.